1. Andersen E. The role of estrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4:197–201.
2. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7:683–92.
3. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418–23 Epub 2003 Jun 26.
4. Vaidyanathan K, Kumar P, Reddy CO, Deshmane V, Somasundaram K, Mukherjee G. “ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women”. Indian J Cancer. 2010;47(1):14–21.
5. Du X, Li XQ, Li L, Xu YY, Feng YM. Breast Cancer Res Treat. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis. 2013;138(1):59–67. doi: 10.1007/s10549-013-2432-2.Epub2013Feb10 .